配位聚合物{[CoL][FeⅡFeⅢ(ox)3·1.5H2O]}∞的合成、波谱表征和磁学性质

A new Schiff base complex， CoL(ClO₄)·3H₂O (1) {L represents condensed from equal molar ratio of sali-cylaldehyde and diethylenetriamine} was synthesized and characterized. Further， a new coordination polymer， {[CoL][Fe^ⅡFe^Ⅲ(ox)₃·1.5H₂O]}_∞ (2)， was synthesized and characterized， where ox^2-=oxalate. The results of the IR and M?ssbauer spectra of 2 revealed that the coordination polymer exists 2-D layer structure in the solid state， and anions layer was formed by [^ⅡFe^Ⅲ(ox)₃]^- unit. The magnetic properties of 2 have been measured and the results indicate that there is magnetic ordering in the low temperature， which may arise from intermolecular ferromagnetic interactions or spin canted effects.     

配位聚合物{[MnL][FeⅡFeⅢ(ox)3·1.5H2O]}∞的合成及其磁学性质

合成和表征了一种新的Schiff碱配合物MnL(ClO4)*3H2O(1)(其中L为n(水杨醛)∶n(二乙撑三胺)=1∶1缩合而成的Schiff碱).1与FeSO4*7H2O和K3[Fe(ox)3]*3H2O(ox=oxalate)进一步反应,生成了双金属层状配位聚合物{[MnL][FeⅡFeⅢ(ox)3]*1.5H2O}∞(2).IR和Mssbauer谱测定结果表明,2具有二维层状结构,其阴离子层由[FeⅡFeⅢ(ox)3]-单元构成.变温磁化率(5K～100K)测试结果表明,2中的自旋载体之间存在反铁磁交换作用.5K时的磁滞现象表明2在低温时可能存在铁磁有序,这可能是亚铁磁或自旋倾斜造成的.     

清除树脂在组合化学中的应用

清除树脂是一种特殊的固相试剂。近五年，它们被广泛的用于平行液相法合成组合化学库，简化液相组合化学库的纯化操作。本文综述了清除树脂在纯化操作中的使用策略。根据清除纯化原理，介绍了共价键型和离子键型两类清除树脂。给出了清除树脂在组合化学中的具体应用实例。最后对清除树脂的发展作了展望。     

Circularly Polarized Absorption Property of Tetra-4[4''''-(2-methylbutoxy)benzoyloxy]phenyl Porphyrin by Introducing Optical Pendant Groups

Circularly polarized luminescent(CPL) materials possess special dissymmetric optical property, i.e. luminescent light having different intensities for left (L) and right(R) circularly polarized components. Recently, these materials have been applied in colour-image projection, stereoscopic displays and light-emitting diodes(LEDS)1-7. We have synthesized a new porphyrin derivative, tetra-4[4'-(2-methylbutoxy)benzoyloxy] phenyl porphyrin [T(MBBP)P], by introducing a chiral group, which p…     

Structures and synthesis of framework Rb and Cs uranyl arsenates and their relationships with their phosphate analogues

Two hydrated uranyl arsenates, Cs₂(UO₂)[(UO₂)(AsO₄)]₄(H₂O)₂ (CsUAs) and Rb₂(UO₂)[(UO₂)(AsO₄)]₄(H₂O)_4.5 (RbUAs), were synthesized by hydrothermal methods. Intensity data were collected at room temperature using MoKα radiation and a CCD-based area detector. The crystal structure of RbUAs was solved by direct methods, whereas the structure model of the phosphate Cs₂(UO₂)[(UO₂)(PO₄)]₄(H₂O)₂ was used for CsUAs; both were refined by full-matrix least-squares techniques on the basis of F² to agreement indices (CsUAs, RbUAs) wR₂=0.061,0.041, for all data, and R₁=0.032,0.021, calculated for 5098, 4991 unique observed reflections (|F_o|>4σ_F), respectively. The compound CsUAs is orthorhombic, space group Cmc2₁, Z=4, a=15.157(2), b=14.079(2), c=13.439(2) Å, V=2867.9(1) Å³. RbUAs is monoclinic, space group C2/m, Z=4, a=13.4619(4), b=15.8463(5), c=14.0068(4) Å, β=92.311(1)°, V=2985.52(2) Å³. The structures consist of sheets of arsenate tetrahedra and uranyl pentagonal bipyramids, with composition [(UO₂)(AsO₄)]⁻, that are topologically identical to the uranyl silicate sheets in uranophane-beta. These sheets are connected by a uranyl pentagonal bipyramid in the interlayer that shares corners with two arsenate tetrahedra on each of two adjacent sheets and whose fifth equatorial vertex is an H₂O group, resulting in an open framework with alkali metal cations in the larger cavities of the structures. CsUAs is isostructural with its phosphate analogue, and has two Cs atoms and a H₂O group in its structural cavities. RbUAs is not isostructural with its phosphate analogue, although it has a homeotypic framework. Its structural cavities are occupied by three Rb atoms and four H₂O groups; one Rb position and three of the interstitial H₂O groups are half-occupied. The partial occupancies of these positions probably result from the accommodation of the larger As atoms (relative to P) in the framework and resultant larger cavities.     

载体对Au-Pd双金属催化剂加氢脱硫性能的影响

研究了Al_2O_3,TiO_2-Al_2O_3等载体对Au-Pd双金属催化剂的噻吩加氢脱硫性能的影响,并运用XRD,TPD,BET,TPR等手段对Au-Pd双金属催化剂进行了表征.结果表明,Au-Pd/TiO_2-Al_2O_3催化剂有较好的噻吩加氢脱硫反应活性和稳定性,与Au-Pd/Al_2O_3催化剂相比,Au-Pd/TiO_2-Al_2O_3催化剂有较高的酸密度和酸强度、活性表面积、H_2及CO的吸附量.     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.     

Preparation of polysiloxane stationary phases for capillary column chromatography: A New methoxyphenyl phase

Contemporary methods for the synthesis of alkyl- and arylsubstituted polysiloxane stationary phases are reviewed. A new, moderately polar phase containing the 3-(4-methoxyphenyl)-propyl group is reported.     

取代邻苯二腈的合成

在室温条件下合成了一系列芳氧基邻苯二腈化合物,应用无素分析、1HNMR、IR确定了它们的结构,讨论了不同取代基对反应的影响.结果表明,酚的芳环上有推电子基时反应容易进行;酚的芳环上有拉电子基时反应慢或不反应.     

Solvothermal Synthesis, Crystal Structure and Electrochemical Property of Complex [Co(p-MBA)2(2,2''-bipy)(H2O)]·(H2O)

One novel complex [Co(p-MBA)2(2,2'-bipy)(H2O)]·(H2O) has been synthesized by the reaction of p-methylbenzoic acid with 2,2'-bipyridine in the solvent mixture of water and methanol. It crystallizes in triclinic, space group P-1 with a=0.70479(14), b=1.1211(2), c=1.6718(3) nm, α=103.806(3), β=90.795(3), γ=104.207(3)°, V=1.2399(4) nm3, Mr=512.41, Dc=1.373 g/cm3, Z=2, F(000)=532, μ=0.733 mm-1, R=0.0432 and wR=0.0957. The crystal structural analysis shows that the cobalt atom is coordinated with three oxygen atoms from two p-methylbenzoic acids and one water molecule and two nitrogen atoms from one 2,2'-bipyridine,forming a distorted square-pyramidal coordination geometry. The cyclic voltammetry behavior of the complex is also reported.